Shan Hwang

Associate Director, Antibody Lead Assessment

Shan is a protein scientist with over 10 years of experience in molecular biology, antibody production, and cell line engineering. She completed her BA at UC Berkeley and her PhD at Yale University, receiving awards and grants from the National Science Foundation and National Institutes of Health. Prior to joining BigHat, Shan led the antibody engineering team at Gritstone Oncology, designing and generating novel anti-CD3 bispecific antibodies and earning inventorship on multiple patents.

About Us

Who we are

We are an interdisciplinary, STEM-focused team supported by experienced leaders, world-class advisors, and top-notch investors.